Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.
("Novel Coronavirus" OR COVID-19 OR SARS-CoV-2 OR 2019-nCoV) AND Controlled Clinical Trial[PT])
11 results
  • A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. [Randomized Controlled Trial]
    N Engl J Med. 2020 05 07; 382(19):1787-1799.Cao B, Wang Y, … Wang C
  • CONCLUSIONS: In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir-ritonavir treatment beyond standard care. Future trials in patients with severe illness may help to confirm or exclude the possibility of a treatment benefit. (Funded by Major Projects of National Science and Technology on New Drug Creation and Development and others; Chinese Clinical Trial Register number, ChiCTR2000029308.).
New Search